Nocturnal Parkinson’s Disease Symptoms Study Group

Overview

To study associate factor of Noctural Parkinson's Disease Symptoms and quality of life in Parkinson's disease patients and caregivers.

Full Title of Study: “Nocturnal Parkinson’s Disease Symptoms Study Group”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Prospective
  • Study Primary Completion Date: August 2013

Interventions

  • Other: Questionaire to assess Noctural Parkinson’s Disease Symptoms
    • Questionaire to assess Noctural Parkinson’s Disease Symptoms and quality of life

Arms, Groups and Cohorts

  • Questionniare

Clinical Trial Outcome Measures

Primary Measures

  • To assess Noctural Parkinson’s Disease Symptoms

Secondary Measures

  • To assess quality of life in Parkinson’s Disease patient
  • To assess quality of life in caregiver of Parkinson’s Disease patient

Participating in This Clinical Trial

Inclusion Criteria

Idiopathic Parkinson's disease patient Exclusion Criteria:

1. Patient with Secondary Parkinsonism eg.Drug-induced Parkinsonism, Vascular Parkinsonism, exposure to toxin, Encephalitis 2. Patient with Atypical Parkinsonial Syndromes eg. Parkinson-plus syndrome, Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD) 3. Patient with Heredodegenerative parkinsonism eg. Spinocerebellar ataxias, Wilson's disease, Juvenile Huntington's disease

Gender Eligibility: All

Minimum Age: 30 Years

Maximum Age: 90 Years

Are Healthy Volunteers Accepted: Accepts Healthy Volunteers

Investigator Details

  • Lead Sponsor
    • Chulalongkorn University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Roongroj Bhidayasiri, Associate Professor – Chulalongkorn University

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.